Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 3
2010 5
2011 7
2012 8
2013 8
2014 4
2015 6
2016 4
2017 11
2018 10
2019 11
2020 9
2021 6
2022 7
2023 2
2024 6
2025 2
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer.
Shiao SL, Gouin KH 3rd, Ing N, Ho A, Basho R, Shah A, Mebane RH, Zitser D, Martinez A, Mevises NY, Ben-Cheikh B, Henson R, Mita M, McAndrew P, Karlan S, Giuliano A, Chung A, Amersi F, Dang C, Richardson H, Shon W, Dadmanesh F, Burnison M, Mirhadi A, Zumsteg ZS, Choi R, Davis M, Lee J, Rollins D, Martin C, Khameneh NH, McArthur H, Knott SRV. Shiao SL, et al. Among authors: ho a. Cancer Cell. 2024 Jan 8;42(1):70-84.e8. doi: 10.1016/j.ccell.2023.12.012. Cancer Cell. 2024. PMID: 38194915 Free article.
Here we employ single-cell transcriptomics and spatial proteomics to profile triple negative breast cancer biopsies taken at baseline, after one cycle of pembrolizumab, and after a second cycle of pembrolizumab given with radiotherapy. ...The other responder group resemble …
Here we employ single-cell transcriptomics and spatial proteomics to profile triple negative breast cancer biopsies taken at baseline …
MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis.
Cho MG, Kumar RJ, Lin CC, Boyer JA, Shahir JA, Fagan-Solis K, Simpson DA, Fan C, Foster CE, Goddard AM, Lerner LM, Ellington SW, Wang Q, Wang Y, Ho AY, Liu P, Perou CM, Zhang Q, McGinty RK, Purvis JE, Gupta GP. Cho MG, et al. Among authors: ho ay. Nature. 2024 Jan;625(7995):585-592. doi: 10.1038/s41586-023-06889-6. Epub 2024 Jan 10. Nature. 2024. PMID: 38200309 Free PMC article.
Furthermore, MRE11-dependent cGAS activation promotes ZBP1-RIPK3-MLKL-mediated necroptosis, which is essential to suppress oncogenic proliferation and breast tumorigenesis. Notably, downregulation of ZBP1 in human triple-negative breast cancer is associated with inc …
Furthermore, MRE11-dependent cGAS activation promotes ZBP1-RIPK3-MLKL-mediated necroptosis, which is essential to suppress oncogenic prolife …
Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial.
Wong JS, Uno H, Tramontano AC, Fisher L, Pellegrini CV, Abel GA, Burstein HJ, Chun YS, King TA, Schrag D, Winer E, Bellon JR, Cheney MD, Hardenbergh P, Ho A, Horst KC, Kim JN, Leonard KL, Moran MS, Park CC, Recht A, Soto DE, Shiloh RY, Stinson SF, Snyder KM, Taghian AG, Warren LE, Wright JL, Punglia RS. Wong JS, et al. Among authors: ho a. JAMA Oncol. 2024 Oct 1;10(10):1370-1378. doi: 10.1001/jamaoncol.2024.2652. JAMA Oncol. 2024. PMID: 39115975 Free PMC article. Clinical Trial.
However, the use of HF after mastectomy in patients undergoing breast reconstruction has not been prospectively examined. OBJECTIVE: To compare HF and CF PMRT outcomes after implant-based reconstruction. ...MAIN OUTCOMES AND MEASURES: The primary outcome was the change in …
However, the use of HF after mastectomy in patients undergoing breast reconstruction has not been prospectively examined. OBJECTIVE: …
Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structures.
Mebane RH, Noel T, Ing N, Gouin KH 3rd, Shah A, Zitser D, Martinez A, Gupta G, Demaria S, Galluzzi L, Ho A, McArthur H, Shiao SL, Knott SRV. Mebane RH, et al. Among authors: ho a. iScience. 2025 Jun 2;28(7):112808. doi: 10.1016/j.isci.2025.112808. eCollection 2025 Jul 18. iScience. 2025. PMID: 40599321 Free PMC article.
We applied single RNA molecule resolution imaging to longitudinal biopsies taken from women with TLS-enriched triple negative breast cancers prior to therapy, after pembrolizumab and after pembrolizumab plus radiation therapy. ...This manuscript describes single RNA molecu …
We applied single RNA molecule resolution imaging to longitudinal biopsies taken from women with TLS-enriched triple negative breast …
Radiotherapy in the setting of breast reconstruction: types, techniques, and timing.
Ho AY, Hu ZI, Mehrara BJ, Wilkins EG. Ho AY, et al. Lancet Oncol. 2017 Dec;18(12):e742-e753. doi: 10.1016/S1470-2045(17)30617-4. Lancet Oncol. 2017. PMID: 29208440 Review.
As the use of breast reconstruction and postmastectomy radiotherapy (PMRT) has increased over the past decade, the typical approach to integrating radiotherapy with breast reconstruction has provoked intense controversy in the management of breast cancer. PMR …
As the use of breast reconstruction and postmastectomy radiotherapy (PMRT) has increased over the past decade, the typical approach t …
Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy.
Horton JK, Jagsi R, Woodward WA, Ho A. Horton JK, et al. Among authors: ho a. Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):23-37. doi: 10.1016/j.ijrobp.2017.08.025. Int J Radiat Oncol Biol Phys. 2018. PMID: 29254776 Review.
Historically, prognosis and treatment decision making for breast cancer patients have been dictated by the anatomic extent of tumor spread. However, in recent years, "breast cancer" has proven to be a collection of unique phenotypes with distinct prognoses, patterns …
Historically, prognosis and treatment decision making for breast cancer patients have been dictated by the anatomic extent of tumor s …
ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations.
McDuff SGR, Bellon JR, Shannon KM, Gadd MA, Dunn S, Rosenstein BS, Ho AY. McDuff SGR, et al. Among authors: ho ay. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1373-1382. doi: 10.1016/j.ijrobp.2021.01.045. Epub 2021 Feb 3. Int J Radiat Oncol Biol Phys. 2021. PMID: 33545302 Review.
PURPOSE: Advances in germline genetic testing have led to a surge in identification of ataxia-telangiectasia mutated (ATM) variant carriers among breast cancer patients, raising numerous questions regarding use of breast radiation therapy (RT) in this population. .. …
PURPOSE: Advances in germline genetic testing have led to a surge in identification of ataxia-telangiectasia mutated (ATM) variant carriers …
Radiation therapy in the management of breast cancer.
Yang TJ, Ho AY. Yang TJ, et al. Among authors: ho ay. Surg Clin North Am. 2013 Apr;93(2):455-71. doi: 10.1016/j.suc.2013.01.002. Surg Clin North Am. 2013. PMID: 23464696 Review.
Radiation reduces local recurrence rates and increases breast cancer-specific survival in patients with early-stage breast cancer after breast-conserving surgery and in node-positive patients who have undergone mastectomy. This article reviews the following t …
Radiation reduces local recurrence rates and increases breast cancer-specific survival in patients with early-stage breast can …
Breast-Conserving Surgery in Bilateral Breast Cancer.
O'Brien JA, Ho A, Wright GP, Stempel M, Patil S, Krause K, Morrow M, Gemignani ML. O'Brien JA, et al. Among authors: ho a. Ann Surg Oncol. 2015 Oct;22(10):3389-96. doi: 10.1245/s10434-015-4746-2. Epub 2015 Aug 12. Ann Surg Oncol. 2015. PMID: 26265365 Free PMC article.
BACKGROUND: Bilateral breast cancer (BBC) may present as synchronous (SBC) or metachronous breast cancer (MBC). ...Contraindication to BCS was defined as any of the following one-breast findings: multicentric disease, tumor considered too large for BCS, and a …
BACKGROUND: Bilateral breast cancer (BBC) may present as synchronous (SBC) or metachronous breast cancer (MBC). ...Contraindic …
94 results